Age ≥ 45 years. Serum PSA level ≥ 4.0 ng/ml. High-risk MRI findings: Presence of at least one lesion with a PI-RADS score of 4 (Likely) or 5 (Highly Likely) according to v2.1 guidelines11.
Fitness for transperineal prostate biopsy under local or general anaesthesia. Competency to provide informed consent.
You may not be if
History of prior prostate biopsy (to ensure baseline risk homogeneity). Prior treatment for prostate cancer or use of 5-alpha reductase inhibitors (5-ARIs) within 6 months.
Candidates who have explicitly opted for focal therapy prior to biopsy (where systematic mapping remains mandatory).
Contraindications to MRI (e.g., incompatible implants, severe renal impairment).
Active urinary tract infection or acute prostatitis.